Cargando…
An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care
OBJECTIVE: Because outcome data inform and drive healthcare decisions and improvement of patient care, this study aimed to gain a deep understanding of sociodemographic profiles and treatment outcomes of newly presenting and recently diagnosed persons living with epilepsy (PwE) at a tertiary epileps...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398151/ https://www.ncbi.nlm.nih.gov/pubmed/30868122 http://dx.doi.org/10.1002/epi4.12304 |
_version_ | 1783399532801818624 |
---|---|
author | Van Steenkiste, Frank Fidèle, Sebera Nsanzabaganwa, Wellars Uwacu, Beni Dedeken, Peter Teuwen, Dirk E. Boon, Paul |
author_facet | Van Steenkiste, Frank Fidèle, Sebera Nsanzabaganwa, Wellars Uwacu, Beni Dedeken, Peter Teuwen, Dirk E. Boon, Paul |
author_sort | Van Steenkiste, Frank |
collection | PubMed |
description | OBJECTIVE: Because outcome data inform and drive healthcare decisions and improvement of patient care, this study aimed to gain a deep understanding of sociodemographic profiles and treatment outcomes of newly presenting and recently diagnosed persons living with epilepsy (PwE) at a tertiary epilepsy center in Rwanda. METHODS: In June 2016 (T1), as a first stage of this single‐center cohort study, an ambispective chart review was conducted on baseline sociodemographic and disease characteristics of PwE using a structured questionnaire. Missing data were obtained by phone interview. In 2017, follow‐up data were collected by phone interview on treatment outcomes after 15‐months (T2). RESULTS: Of 406 PwE screened, 235 were included at T1 and outcomes on 166 PwE were obtained at T2. More than 70% were <20 years of age, with a male preponderance. A high number of patients were aged ≥20 years, were single (67.4%), unemployed (41.5%), and had no formal education or primary level education (53.9%), possibly reflecting stigma. A mean delay in diagnosis since first seizure increased with age at first seizure, amounting to 3 years for patients aged ≥20 years. At T2, 69.6% of 166 patients who could be contacted reported no seizures in the previous month. Valproate monotherapy was the most frequently prescribed treatment. At T2, 47% had discontinued treatment, which was often not recommended by a physician, despite medical insurance coverage in >90% of patients. Only 19% reported an adverse event. Marked and partial improvement in quality of life (QoL) was reported by, respectively, 50.9% and 32.7% of patients. SIGNIFICANCE: Encouraging results on improved seizure control and QoL were observed at follow‐up. The treatment gap remains high due to loss to follow‐up and treatment discontinuation. In this article, we discuss needs and recommendations for improving patient care, requiring concerted efforts of stakeholders at all levels of the healthcare system. |
format | Online Article Text |
id | pubmed-6398151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63981512019-03-13 An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care Van Steenkiste, Frank Fidèle, Sebera Nsanzabaganwa, Wellars Uwacu, Beni Dedeken, Peter Teuwen, Dirk E. Boon, Paul Epilepsia Open Full‐length Original Research OBJECTIVE: Because outcome data inform and drive healthcare decisions and improvement of patient care, this study aimed to gain a deep understanding of sociodemographic profiles and treatment outcomes of newly presenting and recently diagnosed persons living with epilepsy (PwE) at a tertiary epilepsy center in Rwanda. METHODS: In June 2016 (T1), as a first stage of this single‐center cohort study, an ambispective chart review was conducted on baseline sociodemographic and disease characteristics of PwE using a structured questionnaire. Missing data were obtained by phone interview. In 2017, follow‐up data were collected by phone interview on treatment outcomes after 15‐months (T2). RESULTS: Of 406 PwE screened, 235 were included at T1 and outcomes on 166 PwE were obtained at T2. More than 70% were <20 years of age, with a male preponderance. A high number of patients were aged ≥20 years, were single (67.4%), unemployed (41.5%), and had no formal education or primary level education (53.9%), possibly reflecting stigma. A mean delay in diagnosis since first seizure increased with age at first seizure, amounting to 3 years for patients aged ≥20 years. At T2, 69.6% of 166 patients who could be contacted reported no seizures in the previous month. Valproate monotherapy was the most frequently prescribed treatment. At T2, 47% had discontinued treatment, which was often not recommended by a physician, despite medical insurance coverage in >90% of patients. Only 19% reported an adverse event. Marked and partial improvement in quality of life (QoL) was reported by, respectively, 50.9% and 32.7% of patients. SIGNIFICANCE: Encouraging results on improved seizure control and QoL were observed at follow‐up. The treatment gap remains high due to loss to follow‐up and treatment discontinuation. In this article, we discuss needs and recommendations for improving patient care, requiring concerted efforts of stakeholders at all levels of the healthcare system. John Wiley and Sons Inc. 2019-02-21 /pmc/articles/PMC6398151/ /pubmed/30868122 http://dx.doi.org/10.1002/epi4.12304 Text en © 2019 The Authors. Epilepsia Open published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Full‐length Original Research Van Steenkiste, Frank Fidèle, Sebera Nsanzabaganwa, Wellars Uwacu, Beni Dedeken, Peter Teuwen, Dirk E. Boon, Paul An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care |
title | An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care |
title_full | An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care |
title_fullStr | An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care |
title_full_unstemmed | An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care |
title_short | An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care |
title_sort | ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in rwanda and recommendations for improved epilepsy care |
topic | Full‐length Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398151/ https://www.ncbi.nlm.nih.gov/pubmed/30868122 http://dx.doi.org/10.1002/epi4.12304 |
work_keys_str_mv | AT vansteenkistefrank anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare AT fidelesebera anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare AT nsanzabaganwawellars anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare AT uwacubeni anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare AT dedekenpeter anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare AT teuwendirke anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare AT boonpaul anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare AT vansteenkistefrank ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare AT fidelesebera ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare AT nsanzabaganwawellars ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare AT uwacubeni ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare AT dedekenpeter ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare AT teuwendirke ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare AT boonpaul ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare |